Thymic stromal lymphopoietin: a new cytokine in asthma
- 30 June 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 8 (3) , 249-254
- https://doi.org/10.1016/j.coph.2008.03.002
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunityCurrent Opinion in Immunology, 2007
- Mechanisms of virus‐induced asthma exacerbations: state‐of‐the‐art. A GA2LEN and InterAirways documentAllergy, 2007
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsThe Journal of Experimental Medicine, 2007
- Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκBProceedings of the National Academy of Sciences, 2007
- Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitisProceedings of the National Academy of Sciences, 2006
- The immunogenetics of asthma and eczema: a new focus on the epitheliumNature Reviews Immunology, 2004
- A Role for Thymic Stromal Lymphopoietin in CD4+ T Cell DevelopmentThe Journal of Experimental Medicine, 2004
- Overexpression of murine TSLP impairs lymphopoiesis and myelopoiesisBlood, 2004
- Host defense function of the airway epithelium in health and disease: clinical backgroundJournal of Leukocyte Biology, 2003
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002